Prediction of tumor heterogeneity in localized prostate cancer.
Clinical T1 and T2 prostatic carcinoma is a heterogeneous tumor with respect to pathologic stage and outcome. In the authors' experience, 60% of patients have a pT2 prostatic carcinoma, and 2% to 4% have tumors less than 0.5 cm3 in volume. The latter group cannot be predicted by the use of preo...
Автори: | , , , , , , , , , |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2002
|